| Literature DB >> 36147584 |
Jared D Ament1,2,3,4, Amir Vokshoor1,2, Randy Yee3, J Patrick Johnson4.
Abstract
Introduction: For decades, researchers and surgeons have sought to determine the optimal biomaterial for spinal fusion implants. Successful fusion is associated with improved quality of life while failures are often associated with costly and complex revisions. One common failure is subsidence. Biomaterials with higher modulus are thought to be related to subsidence risk but this has not been thoroughly investigated. The aim of this systematic review and meta-analysis is to assess silicon nitride and biomaterial modulus as they relate to subsidence risk in spinal fusions.Entities:
Keywords: biomaterials; spinal fusion; subsidence
Year: 2022 PMID: 36147584 PMCID: PMC9486012 DOI: 10.1016/j.xnsj.2022.100168
Source DB: PubMed Journal: N Am Spine Soc J ISSN: 2666-5484
Figure 1PRISMA Flow Diagram
Haddaway, N. R., Page, M. J., Pritchard, C. C., & McGuinness, L. A. (2022). PRISMA2020: An R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis Campbell Systematic Reviews, 18, e1230. https://doi.org/10.1002/cl2.1230
Summary of Studies
| Study | Quality of Evidence | Study Design | Country | Surgery | Biomaterial | Surgical Indication | Biomaterial by Levels | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ti | PEEK | Si3N4 | n-HA/PA66 | Carbon Fiber | Ti | PEEK | Si3N4 | n-HA/PA66 | Carbon Fiber | ||||||
| Arts et al. 2017 | Good | RCT | Netherlands | ACDF | - | PEEK | Valeo C+CSC (Sintx) | - | - | Cervical Radicular Syndrome | - | C3-4 (1); C4-5 (6); C5-6 (30); C6-7 (10); C7-T1 (1) | C3-4 (1); C5-6 (30); C6-7 (19); C7-T1 (2) | - | - |
| Cabraja et al. 2012 | Good | Retrospective | Germany | ACDF | CeSpace Titan cage with Plasmapore coating (Aesculap) | CeSpace PEEK cage (Aesculap) | - | - | - | Degenerative Disc Disease | C3-4 (1); C4-5 (7); C5-6 (23); C6-7 (13) | C3-4 (6); C4-5 (10); C5-6 (20); C6-7 (6) | - | - | - |
| Chen et al. 2013 | Good | RCT | China | ACDF | SynCage-C (Synthes) | PEEK box cage (Depuy Spine) | - | - | - | Cervical spondylotic myelopathy | C3-6 (14); C4-7 (15) | C3-6 (18); C4-7 (13) | - | - | - |
| McEntire et al. 2020 | Good | RCT | Netherlands | TLIF | - | PEEK cage (Phantom) | ValeoTM OL (Sintx) | - | - | Chronic LBP and disc degeneration of Pfirmann | - | L3-4 (4); L4-5 (19); L5-S1 (23); L5-6 (1); L6-S1 (1); L3-4 (2); L4-5 (2); L5-S1 (1) | L3-4 (6); L4-5 (11); L5-S1 (24); L5-6 (1); L6-S1 (2); L4-5 (7); L5-S1 (1) | - | - |
| Nemoto et al. 2014 | Good | Retrospective | Japan | TLIF | Capstone (Medtronic) | PEEK (Medtronic) | - | - | - | Chronic low back pain (LBP) and irradiating lower extremity symptoms | L4-5 (7); L5-S1 (16) | L4-5 (10); L5-S1 (15) | - | - | - |
| Niu et al. 2010 | Good | Prospective | Taiwan | ACDF | VIGOR-r cage (Advanced | Solis PEEK cage (Stryker) | - | - | - | Cervical degenerative disc disease | C3-4 (6); C4-5 (10); C5-6 (17); C6-7 (4) | C3-4 (2); C4-5 (6); C5-6 (15); C6-74 (10) | - | - | - |
| Wrangel et al. 2017 | Fair | Retrospective | Germany | PLIF | NR | NR | - | - | - | Degenerative lumbar instability | L3-4 (5); L4-5 (6); L5-S1 (6) | L2-3 (2); L3-4 (8); L4-5 (11); L5-S1 (7) | - | - | - |
| Deng et al. 2016 | Fair | Retrospective | China | TLIF | - | Shandong We-go Orthopedic Group Medical Polymer CO | - | Sichuan University and Department of Orthopedics, The First Affiliated Hospital of Chongqing Medical University | - | Degenerative or isthmus spondylolisthesis, degenerative disc disease, lumbar stenosis, lumbar disc herniation or recurrent lumbar disc herniation | - | - | - | L2-3 (2); L3-4 (16); L4-5 (86); L5-S1 (55) | L1-2 (4); L2-3 (1); L3-4 (21); L4-5 (89); L5-S1 (63) |
| Hu et al. 2019a | Good | Retrospective | China | ACCF | Titanium Mesh Cage | - | - | NR | - | Cervical spondylosis | C4 (7); C5 (25); C6 (20) | - | - | C4 (9); C5 (29); C6 (17) | - |
| Hu et al. 2019b | Good | Retrospective | China | ACDF | - | NR | - | NR | - | Cervical spondylosis | - | C3-4 (5); C4-5 (10); C5-6 (18); C6-7 (14) | - | C3-4 (4); C4-5 (12); C5-6 (22); C6-7 (13) | - |
| Yang et al. 2013 | Good | RCT | China | ACCF | Titanium Mesh Cage (Medtronic Sofamor Danek) | - | - | Cage (Sichuan National | - | Cervical degenerative diseases | C3 (3); C4 (8); C5 (15); C6 (6) | - | - | C3 (3); C4 (11); C5 (13); C6 (8) | - |
| Yoo et al. 2014 | Good | Retrospective | South Korea | ACDF | - | Solis PEEK cage (Stryker) | - | - | Carbon fiber composite frame cages (Co-Ligne AG) | Cervical degenerative diseases | - | C3-4 (1); C4-5 (4); C5-6 (16); C6-7 (2) | - | - | C3-4 (3); C4-5 (2); C5-6 (20); C6-7 (10) |
| Zhang et al. 2014 | Fair | Retrospective | China | ACCF | Titanium Mesh Cage (Medtronic Sofamor Danek) | - | - | Cage (Sichuan National | - | Multilevel cervical spondylotic myelopathy | C4 (6); C5 (16); C6 (3); C4-5 (10); C5-6 (11) | - | - | C4 (7); C5 (36); C6 (9); C4-5 (11); C5-6 (8) | - |
*NR = not reported
Ti = titanium
PEEK = polyetheretherketone
Si3N4 = silicon nitride
n-HA/PA66 = nano-hydroxyapatite/polyamide66
Patient Demographics by Included Study:
| Study | Number of Patients (Female/Male) | Age (range or ±SD) | Smoking Status | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ti | PEEK | Si3N4 | n-HA/PA66 | Carbon Fiber | Ti | PEEK | Si3N4 | n-HA/PA66 | Carbon Fiber | Ti | PEEK | Si3N4 | |||
| Arts et al. 2017 | - | 48 (23/25) | 52 (23/29) | - | - | - | 49.4 [28-67] | 53.3 [34-74] | - | - | - | 39.6% (19/48) | 46.2% (24/52) | - | - |
| Cabraja et al. 2012 | 44 (18/26) | 42 (14/28) | - | - | - | 51.1 ± 8.9 | 57.6 ± 11.1 | - | - | - | 61.4% (27/44) | 52.4% (22/42) | - | - | - |
| Chen et al. 2013 | 29 (12/14) | 31 (15/16) | - | - | - | 45.7 ± 7.2 | 47.2 ± 6.8 | - | - | - | 24.1% (7/29) | 25.8% (8/31) | - | - | - |
| McEntire et al. 2020 | - | 48 (33/15) | 44 (28/16) | - | - | - | 53.0 ± 9.5 | 55.2 ± 11.7 | - | - | - | 35.4% (17/48) | 27.3% (12/44) | - | - |
| Nemoto et al. 2014 | 23 (1/22) | 25 (2/23) | - | - | - | 40.7 ± 10.2 | 42.9 ± 10.4 | - | - | - | NR | NR | - | - | - |
| Niu et al. 2010 | 28 (13/15) | 25 (13/12) | - | - | - | 49.5 ± 11.5 | 52.2 ± 10.5 | - | - | - | NR | NR | - | - | - |
| Wrangel et al. 2017 | 15 (5/10) | 25 (18/7) | - | - | - | 63 ± 12 | 69 ± 10 | - | - | - | NR | NR | - | - | - |
| Deng et al. 2016 | - | 142 (82/60) | - | 124 (63/61) | - | - | 53.65 ± 14.43 | - | 53.28 ± 12.51 | - | - | NR | - | NR | - |
| Hu et al. 2019a | 52 (24/28) | - | 55 (29/26) | - | 54.9 ± 9.5 | - | - | - | 56.5 ± 10.4 | NR | - | - | NR | - | |
| Hu et al. 2019b | - | 51 (23/28) | - | 47 (22/25) | - | - | 51.3 ± 9.5 | - | 52.5 ± 10.4 | - | - | 15.7% (8/51) | - | 21.3% (10/47) | - |
| Yang et al. 2013 | 32 (12/20) | - | - | 35 (13/22) | - | 46.8 ± 7.2 | - | - | 47.6±7.1 | - | 31.3% (10/32) | - | - | 40.0% (14/35) | - |
| Yoo et al. 2014 | - | 23 (13/10) | - | - | 35 (13/22) | - | 53.9 | - | - | 51.8 | - | 34.8% (8/23) | - | - | 40.0% (14/35) |
| Zhang et al. 2014 | 46 (22/24) | - | - | 71 (30/41) | - | 1 level 55.04 ± 11.09; 2 level 57.81 ± 11.50 | - | - | 1 level 56.56 ± 12.13; 2 level 57.00 ± 10.95 | - | NR | - | - | NR | - |
*NR = not reported
Ti = titanium
PEEK = polyetheretherketone
Si3N4 = silicon nitride
n-HA/PA66 = nano-hydroxyapatite/polyamide66
Summary of Subsidence Definition, Follow-up, Modality Used for Assessment, Events:
| Study | Definition | Mean Follow-up | Modality | Results (Events) | ||||
|---|---|---|---|---|---|---|---|---|
| Ti | PEEK | Si3N4 | n-HA/PA66 | Carbon Fiber | ||||
| Arts et al. 2017 | [≥2 mm] | 24 months (last) | CT and Medical Metrics, | - | 52.2% (24/46) | 50.0% (23/46) | - | - |
| Cabraja et al. 2012 | ≥2 mm | 28.4 months | NR | 20.5% (9/44) | 14.3% (6/42) | - | - | - |
| Chen et al. 2013 | ≥3 mm | 99.7 months | NR | 34.5 % (17/87) | 5.4% (5/93) | - | - | - |
| McEntire et al. 2020 | ≥2 mm | 24 months (last) | X-Ray and CT | - | 0.0% (0/53) | 0.0% (0/52) | - | - |
| Nemoto et al. 2014 | ≥2 mm | 24 months (last) | CT | 34.8% (8/23) | 28.0% (7/25) | - | - | - |
| Niu et al. 2010 | ≥3 mm | Ti 31.9 ± 3.4; PEEK 30.4 ± 3.3 | NR | 16.2% (6/37) | 0% (0/34) | - | - | - |
| Wrangel et al. 2017 | NR | Ti 62 ± 13; Peek 39 ± 12 | CT | 0.0% (0/15) | 0.0% (0/25) | - | - | - |
| Deng et al. 2016 | >3 mm | PEEK 14.61 ± 4.08; n-HA/PA66 14.69 ± 4.13 | CT | - | 9.0% (16/178) | - | 7.6% (12/159) | - |
| Hu et al. 2019a | ≥3 mm; radiographic > 2 mm | Ti 102.4 ± 4.6; n-HA/PA66 103.6 ± 6.3 | X-Ray and CT | 40.4% (22/52) | - | - | 18.2% (10/55) | - |
| Hu et al. 2019b | radiographic >2 mm | PEEK 95.4 ± 8.4; n-HA/PA66 98.6 ± 11.3 | CT | - | 9.8% (5/51) | - | 10.6% (5/47) | - |
| Yang et al. 2013 | >3 mm | 48 months (last) | CT | 21.9% (7/32) | - | - | 5.7% (2/35) | - |
| Yoo et al. 2014 | >3 mm | 24 months | MRI | - | 26.1% (6/23) | - | - | 34.3% (12/35) |
| Zhang et al. 2014 | >3 mm | 45.28 ± 12.83 months | CT | 30.4% (14/46) | - | - | 4.2% (3/71) | - |
NR = not reported
Figure 2Node-split Analysis
Figure 3Meta-Analysis Forest Plot
Figure 4Treatment Ranking
Figure 5a. Forest Plot: n-HA/PA66 vs Ti
b. Forest Plot: n-HA/PA66 vs PEEK
c. Forest Plot: PEEK vs Ti
d. Forest Plot: Si3N4 vs PEEK
e. Forest Plot: CFRP vs PEEK
Figure 6Funnel Plot
Ranking Probabilities (Extended Model):
| Rank 1 | Rank 2 | Rank 3 | Rank 4 | Rank 5 | |
|---|---|---|---|---|---|
| 0.14 | 0.12 | 0.15 | 0.42 | 0.17 | |
| 0.45 | 0.32 | 0.16 | 0.07 | 0.00 | |
| 0.06 | 0.35 | 0.46 | 0.13 | 0.00 | |
| 0.35 | 0.21 | 0.22 | 0.18 | 0.04 | |
| 0.00 | 0.00 | 0.02 | 0.19 | 0.79 |